Home›Companies›Biotech & Pharma›Lyora Therapeutics

Lyora Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 11, 2025·Suggest an edit

About Lyora Therapeutics

Lyora Therapeutics is a private company based in Belmont, Massachusetts, incorporated in 2024 in Delaware. It has reported $525,000 raised in one offering on Form D since March 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 25, 2025Mar 11, 2025$525,000of $2.0M target4$131KOptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Lyora Therapeutics's Form D filed Mar 11, 2025.

LP
Luc Vandenberghe, PhD
President and director

Sources

  1. SECLyora Therapeutics, Inc. filing history